BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang Q, Chung CY, Rosenberg JN, Yu G, Betenbaugh MJ. Application of the CRISPR/Cas9 Gene Editing Method for Modulating Antibody Fucosylation in CHO Cells. Methods Mol Biol 2018;1850:237-57. [PMID: 30242691 DOI: 10.1007/978-1-4939-8730-6_16] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Zhang J, Shan L, Liang F, Du C, Li J. Strategies and Considerations for Improving Recombinant Antibody Production and Quality in Chinese Hamster Ovary Cells. Front Bioeng Biotechnol 2022;10:856049. [DOI: 10.3389/fbioe.2022.856049] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Yang G, Wang Q, Chen L, Betenbaugh MJ, Zhang H. Glycoproteomic Characterization of FUT8 Knock-Out CHO Cells Reveals Roles of FUT8 in the Glycosylation. Front Chem 2021;9:755238. [PMID: 34778211 DOI: 10.3389/fchem.2021.755238] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
3 Wang Q, Wang T, Zhang R, Yang S, McFarland KS, Chung CY, Jia H, Wang LX, Cipollo JF, Betenbaugh MJ. The interplay of protein engineering and glycoengineering to fine-tune antibody glycosylation and its impact on effector functions. Biotechnol Bioeng 2021. [PMID: 34647616 DOI: 10.1002/bit.27953] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
4 Narimatsu Y, Büll C, Chen YH, Wandall HH, Yang Z, Clausen H. Genetic glycoengineering in mammalian cells. J Biol Chem 2021;296:100448. [PMID: 33617880 DOI: 10.1016/j.jbc.2021.100448] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 12.0] [Reference Citation Analysis]
5 Lu X, Guo Y, Gu S, Tan D, Cheng B, Li Z, Huang W. An efficient and precise method for generating knockout cell lines based on CRISPR-Cas9 system. Eng Life Sci 2020;20:585-93. [PMID: 33304232 DOI: 10.1002/elsc.202000032] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
6 Donald LJ, Spearman M, Mishra N, Komatsu E, Butler M, Perreault H. Mass spectrometric analysis of core fucosylation and sequence variation in a human-camelid monoclonal antibody. Mol Omics 2020;16:221-30. [PMID: 32163054 DOI: 10.1039/c9mo00168a] [Reference Citation Analysis]
7 Ziegler M, Takors R. Reduced and Minimal Cell Factories in Bioprocesses: Towards a Streamlined Chassis. Minimal Cells: Design, Construction, Biotechnological Applications 2020. [DOI: 10.1007/978-3-030-31897-0_1] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]